Recommendation of first chikungunya vaccine for persons as young as 12 years old expands access for US travelers to regions with outbreak or ...

By Mariam Sunny and Kamal Choudhury (Reuters) -The U.S. Food and Drug Administration has approved a prefilled syringe version ...

Vancouver Coastal Health officials are urging residents, especially men who have sex with other men, to see if they are fully immunized against mpox amid a recent rise in cases.

Vaccination: (From the Provincial Board of Health to all school boards in the province): British Columbia is threatened with an epidemic of Smallpox. In 1922 there were 64 cases reported in the ...

The Food and Drug Administration (FDA) has approved a new freeze-dried formulation of Jynneos ® (smallpox and mpox vaccine, live, non-replicating). Prior to this approval, Jynneos had only been ...

which started with Dr. Edward Jenner who created the world’s first successful vaccine for smallpox in 1796. Initially, many were uncertain about the process fearing they could contract cowpox through ...

This marked the first WHO-prequalified syringe product in Rwanda, underscoring Africa's growing capacity for producing essential vaccine syringes locally, said TKMD Rwanda. The syringes ...

We observed tasks in the vaccine preparation process, from the time of removal of the vial or the syringe package from the refrigerator until the time it was ready to be administered to a patient.

Vaccines administered concurrently must be at different injection sites, using separate needles and syringes. IMD occurs sporadically worldwide and in focal epidemics. IMD is endemic in Canada, but ...

In many ways, smallpox represented a natural choice for the earliest explorations into systematic vaccination because of its historical position as the greatest disease scourge of mankind.

Measles patients with breakthrough cases typically have milder illness. As measles has spread across the United States, the overwhelming majority of cases have been among unvaccinated people or ...

On March 10, Dr. Nisha Acharya got a letter from the National Institutes of Health terminating her grant to study the safety and effectiveness of a vaccine recommended for all adults 50 and older ...